Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0E3ED
|
|||
| Drug Name |
Octahydro-pyrrolo[3,4-c]-pyrrole derivative 1
|
|||
| Synonyms |
PMID28447479-Compound-7
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
HOFFMANN LA ROCHE [CHHOFFMANN LA ROCHE [US]
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C23H23F4N3O5S
|
|||
| Canonical SMILES |
C1C2CN(CC2CN1C(=O)CCC3=C(C=C(C=C3)OC(F)(F)F)F)C(=O)C4=CC=C(C=C4)S(=O)(=O)N
|
|||
| InChI |
1S/C23H23F4N3O5S/c24-20-9-18(35-23(25,26)27)5-1-14(20)4-8-21(31)29-10-16-12-30(13-17(16)11-29)22(32)15-2-6-19(7-3-15)36(28,33)34/h1-3,5-7,9,16-17H,4,8,10-13H2,(H2,28,33,34)/t16-,17+
|
|||
| InChIKey |
MRXFENNJFHPMOW-CALCHBBNSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Extracellular lysophospholipase D (E-NPP2) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Extracellular lysophospholipase D (E-NPP2) | Target's Patent Info | [1] | |
| KEGG Pathway | Ether lipid metabolism | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Autotaxin inhibitors: a patent review (2012-2016).Expert Opin Ther Pat. 2017 Jul;27(7):815-829. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.